Global Blood Cancer Diagnostics Market Size & Outlook

The global blood cancer diagnostics market size was estimated at USD 10,826.2 million in 2024 and is projected to reach USD 16,040.2 million by 2030, growing at a CAGR of 6.8% from 2025 to 2030.
Revenue, 2024 (US$M)
$10,826.2
Forecast, 2030 (US$M)
$16,040.2
CAGR, 2025 - 2030
6.8%
Report Coverage
Worldwide

Global blood cancer diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global blood cancer diagnostics market highlights

  • The global blood cancer diagnostics market generated a revenue of USD 10,826.2 million in 2024 and is expected to reach USD 16,040.2 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 6.8% by 2030.
  • In terms of segment, assay kits and reagents accounted for a revenue of USD 7,840.5 million in 2024.
  • Assay Kits and Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 10,826.2 million
Market revenue in 2030USD 16,040.2 million
Growth rate6.8% (CAGR from 2025 to 2030)
Largest segmentAssay kits and reagents
Fastest growing segmentAssay Kits and Reagents
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Assay Kits and Reagents

Other key industry trends

  • In terms of revenue, the North America accounted for 37.7% of the global blood cancer diagnostics market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, China is the fastest growing regional market and is projected to reach USD 1,612.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Blood Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website
SkylineDx View profile 11-50 Rotterdam, Zuid-Holland, The Netherlands, Europe http://www.skylinedx.com/
Invivoscribe, Inc. View profile 251-500 San Diego, California, United States, North America https://www.invivoscribe.com
Abbott View profile - - -
QIAGEN View profile - - -
Danaher Corporation View profile - - -
Adaptive Biotechnologies View profile 501-1000 Seattle, Washington, United States, North America http://adaptivebiotech.com
Sophia Genetics SA View profile 449 La Pièce 12, Rolle, Switzerland, CH-1180 https://www.sophiagenetics.com
Bio-Techne Corp View profile 3050 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 https://www.bio-techne.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com

Global blood cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood cancer diagnostics market will help companies and investors design strategic landscapes.


Assay kits and reagents was the largest segment with a revenue share of 72.42% in 2024. Horizon Databook has segmented the Global blood cancer diagnostics market based on instruments, assay kits and reagents covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Blood Cancer Diagnostics Product Outlook (Revenue, USD Million, 2018-2030)
    • Instruments
    • Assay Kits and Reagents
  • Global Blood Cancer Diagnostics Test Outlook (Revenue, USD Million, 2018-2030)
    • Biopsy
    • Imaging Tests
    • Blood Tests
    • Molecular Test
  • Global Blood Cancer Diagnostics Enduse Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals and Clinics
    • Diagnostic Labs
    • Research Institutes

Reasons to subscribe to Global blood cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global blood cancer diagnostics market databook

  • Our clientele includes a mix of blood cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global blood cancer diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global blood cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global blood cancer diagnostics market size, by regions, 2018-2030 (US$M)

Top 10 countries: Blood cancer diagnostics market size, 2024 (US$M)

Global blood cancer diagnostics market share, by product, 2024 & 2030 (%, US$M)

Blood cancer diagnostics market: Opportunity assessment by country

Global blood cancer diagnostics market, by region, 2024 (US$M)

Global blood cancer diagnostics market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online